• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Leflunomide may be option for psoriatic arthritis

Article

SAN FRANCISCO - The disease modifying antirheumatic drug (DMARD) leflunomide (Arava), approved for use in rheumatoid arthritis, may also be an effective therapy for recalcitrant psoriatic arthritis and psoriasis, according to two new studies.

Recent Videos
Related Content
Combining Microneedling and Tranexamic Acid for Melasma: Efficacy and Satisfaction

Combining Microneedling and Tranexamic Acid for Melasma: Efficacy and Satisfaction

Article
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

Podcast
Xkin Suture Device Acts as Effective Wound Closure Method, Improves Scar Outcomes

Xkin Suture Device Acts as Effective Wound Closure Method, Improves Scar Outcomes

Article
The Cutaneous Connection: Enhancing Vitiligo Care With Nanette Silverberg, MD

The Cutaneous Connection: Enhancing Vitiligo Care With Nanette Silverberg, MD

Podcast
Insights into Bimekizumab 2-Year Data for PsA, nr-asSpA, and AS

Insights into Bimekizumab 2-Year Data for PsA, nr-asSpA, and AS

Article
Physicians Should Prepare for Potential Acne Vulgaris Misinformation Correction, Report Says

Physicians Should Prepare for Potential Acne Vulgaris Misinformation Correction, Report Says

Article
© 2024 MJH Life Sciences

All rights reserved.